Dr. Warner W. Carr, MD

Dr. Carr practices at Allergy & Asthma Associates of Southern Calif Inc in Irvine, California.

Dr. Carr's NPI, 1184798001, was assigned on November 20, 2006. Dr. Carr graduated from University Of Washington School Of Medicine in 1996. Dr. Carr holds California license A-98901.

Dr. Carr's primary practice is Allergy & Asthma Associates of Southern Calif Inc, at 15785 Laguna Canyon Rd, Irvine, CA 92618 in Orange County. The practice phone is (949) 364-2900.

Dr. Carr's primary practice is Allergy & Asthma Associates of Southern Calif Inc in Irvine, California. Dr. Carr is also affiliated with Providence Mission Hospital. The medical group on file is OSO Home Care, Inc. Dmand AI also links Dr. Carr to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carr practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Carr's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Carr is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Carr's licenses on file in 3 states: California, Maryland and Idaho.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Carr treats.

CMS data shows 3,614 Medicare services from Dr. Carr across 12 procedure codes in 2024, for 191 Medicare patients. Medicare paid $62,049 for them. Every service was in an office.

CMS counts 191 Medicare patients who saw Dr. Carr in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high cholesterol, and 61% have asthma. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carr's median patient age at 36, with 54% women.

In 2024, Dr. Carr wrote 1,666 Medicare Part D claims for 338 patients. 58% of them were for generic drugs. CMS names the drug for 1,489 of them, across 31 drugs with 11 or more claims each, at $895,846 in total drug cost. In 2023, CMS named 1,477 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Carr for performance year 2024, reported as part of a group. Dr. Carr accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 66 papers to Dr. Carr, published from 2009 to 2024. 2021 was the busiest year, with 7. The most frequent topics are Asthma, Double-Blind Method and Rhinitis, Allergic, Seasonal. Dr. Carr has published most often in Allergy Asthma Proc. Dr. Carr's most frequent co-authors are Thomas B. Casale, MD, Bradley Elliott Chipps, MD and Eli Owen Meltzer, MD.

Dmand AI links Dr. Carr to 3 clinical trials. Conditions studied include Peanut Hypersensitivity, Nut and Peanut Hypersensitivity and Asthma. Open Payments lists research payments to Dr. Carr that name 1 trial.

CMS Open Payments shows 1,235 general payments to Dr. Carr from 55 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. AstraZeneca Pharmaceuticals LP paid the most, $267,910. It also lists 25 research payments totaling $29,182 from 2016 to 2024, naming 1 clinical trial.

Dmand AI lists 33 awards for Dr. Carr, most recently Top Doctors:LA Area in 2013.

Dr. Carr graduated from University Of Washington School Of Medicine in 1996. Dr. Carr is a member of AAAAI and ACP.

Dr. Carr is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.